Jim brings over 12 years of experience in commercial strategy, global sales management and execution, business and product development. He has over 9 years of expertise in biopharma market research, intelligence, and data. Prior to AdverseEvents, Jim served as the Global Head of Sales for the BioPharm Solutions Suite at Infinata, Inc. (A part of The Mergermarket Group, a Financial Times Group company and a division of Pearson, Plc.) During his time at Infinata, he was responsible for the commercial oversight of the product suite; Developing, implementing and executing upon a commercial strategy surrounding all of the key players in the life science ecosystem including drug/device developers, contract research organizations (CROs), professional services, financial markets, and government agencies. He was also tasked with identifying, introducing and vetting potential M&A, JV, and licensing opportunities for the business. Prior to Infinata, Jim was the Global Commercial Director for Datamonitor’s Healthcare Financial Markets division, after working closely with AEI founder and President, Brian Overstreet at Sagient Research Systems, Inc. Jim started his professional career at Bloomberg, LP and received a B.S. in Marketing from Providence College.
Jim Davis
